China SXT Pharmaceuticals SXTC Growth Metrics (2018-2026)

NASDAQ SXTC
$2.81 +0.29 (+11.51%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

China SXT Pharmaceuticals Quarterly Growth Metrics

Periods 17 quarters
Latest Mar 2026

China SXT Pharmaceuticals reported asset growth of 60.43% for the quarter ended Mar 2026. These growth metrics cover 17 quarters of results from Mar 2018 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Mar2018 Dec2018 Mar2019 Sep2019 Mar2020 Sep2020 Mar2021 Sep2021 Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Growth Ratios
Assets Growth (1y) 128.14%189.84%24.22%4.33%59.19%-5.71%-2.90%-2.16%-11.90%-34.23%-21.75%112.49%-6.33%-14.98%60.43%
Assets Growth (3y) 65.24%41.80%24.29%-1.27%10.84%-15.34%-12.52%10.99%-13.56%5.91%5.55%
Assets Growth (5y) 31.01%12.90%5.77%6.11%-0.04%1.85%0.12%
Capital Expenditures Growth (1y)Capex Growth (1y) -143.35%
Capital Expenditures (QoQ)Capex (QoQ) -22.89%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 5,650.21%1,312.65%2,322.26%-21.58%11.42%83.33%-99.70%0.00%49,609.84%30.01%11.55%-30.46%6.59%49.86%14.33%55.68%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 172.84%-56.62%12.86%18.77%33.58%18.82%-3.31%739.23%10.65%10.78%17.50%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) 92.46%114.38%5.38%14.78%19.96%15.38%16.10%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 5,650.21%71.47%1,312.65%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -463.97%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 41.94%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 555.25%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -163.18%
Free Cash Flow Growth (1y)FCF Growth (1y) 398.96%
Free Cash Flow (QoQ)FCF (QoQ) -128.75%
Net Cash Flow Growth (1y)NCF Growth (1y) 888.39%
Net Cash Flow (QoQ)NCF (QoQ) 1,195.27%
Net Income Growth (1y) 0.21%-116.27%
Net Income (QoQ) -145.70%-198.64%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 0.21%-116.27%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -145.70%-198.64%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 34.37%126.31%35.87%-16.89%-8.96%-11.37%-14.35%-21.86%-21.63%-20.13%-65.82%-71.55%-45.70%-33.48%-34.42%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) 18.45%18.57%1.94%-16.82%-15.14%-17.91%-38.78%-43.80%-47.41%-46.74%-50.44%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y) 2.21%0.79%-22.27%-33.43%-35.30%-36.33%-39.41%
Total Debt Growth (1y) -21.36%2,523.83%2,120.13%-98.79%-99.35%-60.57%4,613.57%4,916.67%-85.67%-67.37%115.40%110.02%27.82%27.50%23.83%
Total Debt Growth (3y) -51.69%-50.02%89.05%-37.97%-64.80%86.20%144.11%225.17%-26.66%-4.40%50.51%
Total Debt Growth (5y) -5.31%15.36%15.83%-30.38%-34.56%76.82%87.26%

China SXT Pharmaceuticals Growth Metrics API

Pull China SXT Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SXTC&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY